Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Patients with limited English prefer professional language interpretation in otolaryngology clinics.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Alopecia patients in the UK want more empathy and better care from healthcare providers, including more GP training on alopecia and improved care pathways.

Patients with skin of color are more likely to use supplements for hair loss than Caucasian patients, but the effectiveness of these supplements is uncertain and they can be expensive.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Patients were very satisfied with the multidisciplinary group visit for alopecia areata.

Patients and doctors often disagree on alopecia areata severity and treatment satisfaction.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Patients with lichen planopilaris/frontal fibrosing alopecia have a higher rate of vitamin D deficiency than the general US population.

Patients with deficiency syndrome, especially qi deficiency, have a higher risk of type 2 heart attacks.

Patients with psoriasis ranked symptom control and treatment efficacy as most important for their care.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Patients need better information about the risks of long-term steroid use.

Patients with metabolic syndrome often have skin problems like acanthosis nigricans and skin tags, and early treatment is important to prevent serious issues.

Patients with pernio have lower vitamin B12 and ferritin levels than healthy people.

Patients with Telogen effluvium have higher levels of heavy metals than healthy individuals.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Patients with multiple superficial venous thrombosis are at greater risk for serious complications like cancer and recurrent blood clots.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

Patients with alopecia areata had higher TSH levels.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

The document concludes that while some advocate for a patient voucher system, it may be unequal and current healthcare reforms should be given a chance, and it also recommends various medical books for their comprehensive coverage and advice on specific health issues.